Aristotle Capital Boston’s Cohen & Steers CNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12M Sell
191,162
-9,537
-5% -$622K 0.74% 62
2025
Q4
$12.6M Buy
200,699
+175,063
+683% +$11.4M 0.69% 67
2025
Q3
$1.68M Sell
25,636
-1,349
-5% -$98.8K 0.09% 120
2025
Q2
$2.03M Sell
26,985
-3,166
-11% -$243K 0.1% 114
2025
Q1
$2.42M Sell
30,151
-15,251
-34% -$1.3M 0.12% 114
2024
Q4
$4.19M Sell
45,402
-57,039
-56% -$5.64M 0.16% 112
2024
Q3
$9.83M Sell
102,441
-29,739
-22% -$2.53M 0.33% 92
2024
Q2
$9.59M Sell
132,180
-34,240
-21% -$2.43M 0.32% 94
2024
Q1
$12.8M Sell
166,420
-14,937
-8% -$1.07M 0.39% 90
2023
Q4
$13.7M Sell
181,357
-27,799
-13% -$1.67M 0.42% 91
2023
Q3
$13.1M Sell
209,156
-3,946
-2% -$250K 0.42% 90
2023
Q2
$12.4M Buy
213,102
+9,306
+5% +$543K 0.37% 96
2023
Q1
$13M Buy
203,796
+10,608
+5% +$740K 0.4% 91
2022
Q4
$12.5M Sell
193,188
-7,752
-4% -$486K 0.39% 98
2022
Q3
$12.6M Sell
200,940
-37,429
-16% -$2.68M 0.43% 101
2022
Q2
$15.2M Sell
238,369
-13,574
-5% -$1.03M 0.45% 101
2022
Q1
$21.6M Buy
251,943
+2,870
+1% +$238K 0.55% 82
2021
Q4
$23M Sell
249,073
-17,154
-6% -$1.59M 0.54% 80
2021
Q3
$22.3M Buy
266,227
+1,523
+0.6% +$129K 0.52% 85
2021
Q2
$21.7M Sell
264,704
-6,727
-2% -$485K 0.5% 85
2021
Q1
$17.7M Sell
271,431
-36,239
-12% -$2.48M 0.39% 103
2020
Q4
$22.9M Sell
307,670
-56,547
-16% -$3.73M 0.54% 82
2020
Q3
$20.3M Buy
364,217
+20,973
+6% +$1.29M 0.59% 69
2020
Q2
$23.4M Sell
343,244
-3,567
-1% -$215K 0.71% 55
2020
Q1
$15.8M Sell
346,811
-48,804
-12% -$3.09M 0.67% 58
2019
Q4
$24.8M Sell
395,615
-3,142
-0.8% -$199K 0.68% 65
2019
Q3
$21.9M Sell
398,757
-35,152
-8% -$1.86M 0.64% 66
2019
Q2
$22.3M Buy
433,909
+16,070
+4% +$788K 0.7% 62
2019
Q1
$17.7M Buy
417,839
+320,053
+327% +$12.4M 0.59% 75
2018
Q4
$3.36M Buy
97,786
+21,299
+28% +$788K 0.27% 104
2018
Q3
$3.11M Buy
76,487
+9,490
+14% +$398K 0.23% 105
2018
Q2
$2.79M Sell
66,997
-254,071
-79% -$10.2M 0.22% 104
2018
Q1
$13.1M Buy
321,068
+165,366
+106% +$6.94M 0.61% 74
2017
Q4
$7.36M Buy
155,702
+68,737
+79% +$3.03M 0.54% 86
2017
Q3
$3.43M Buy
86,965
+35,510
+69% +$1.41M 0.31% 106
2017
Q2
$2.09M Buy
51,455
+30,379
+144% +$1.21M 0.23% 105
2017
Q1
$842K Buy
21,076
+2,027
+11% +$73.3K 0.11% 114
2016
Q4
$640K Buy
+19,049
New +$696K 0.09% 118
2016
Q2
Sell
-165
Closed -$6K 104
2016
Q1
$6K Buy
+165
New +$5.19K ﹤0.01% 111

Other funds holding CNS

Aristotle Capital Boston's CNS Position: Q1 2026 in Review

Aristotle Capital Boston reduced its Cohen & Steers (CNS) stake by 4.8% in Q1 2026, selling an estimated $622K and leaving 191,162 shares worth $12M. The position accounts for 0.74% of the portfolio, ranked #62.

Aristotle Capital Boston first reported a position in CNS in Q1 2016 and has held it in 39 quarters since. The position peaked at $24.8M in Q4 2019. 294 funds tracked by Wall St. Rank hold CNS as of Q1 2026.

  • Aristotle Capital Boston held 191,162 shares of Cohen & Steers worth $12M as of Q1 2026.
  • Aristotle Capital Boston sold 9,537 Cohen & Steers shares in Q1 2026, an estimated $622K.
  • Cohen & Steers made up 0.74% of Aristotle Capital Boston's portfolio in Q1 2026, its #62 holding.
  • Aristotle Capital Boston first reported a position in Cohen & Steers in Q1 2016 and has held it in 39 quarters since.
  • Aristotle Capital Boston's Cohen & Steers position peaked at $24.8M in Q4 2019.
  • 294 funds tracked by Wall St. Rank held Cohen & Steers as of Q1 2026.

Based on Aristotle Capital Boston's 13F filing for Q1 2026, filed 15 May 2026.